MedPath

The Comparison of efficacy of Levetiracetam and Carbamazepine in the treatment of Rolandic seizures in childre

Phase 3
Recruiting
Conditions
Rolandic seizure.
Epilepsy and recurrent seizures
Registration Number
IRCT20190208042654N3
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
94
Inclusion Criteria

Children with BECTS (clinical diagnosis and EEG in favor of Rolandic epilepsy) with more than two attacks per year
Medicated with only one drug
Age above 4 years under 12 years and
Normal MRI

Exclusion Criteria

Lack of consent to enter the study
Severe side effects and drug reactions to Levetiracetam or Carbamazepine
Multi-drug therapy
Inability to follow up the patients

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency, duration, and severity of seizure attacks and drug side effects. Timepoint: before treatment and every two months for 6 months. Method of measurement: Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath